Valuation UCB OTC Markets

Stocks

Market Closed - OTC Markets 15:27:19 2026-10-05 EDT			5-day change	1st Jan Change
235.44 ^USD	-1.30%		-4.34%	-19.80%

09-30	Merck's experimental skin disease drug succeeds in mid-stage study	RE
09-29	UCB Presents Data From Innovative Myasthenia Gravis Portfolio At AANEM Annual Meeting And MGFA Scientific Session	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,947	13,973	14,969	36,464	45,333	38,304	-	-
Change	-	-26.25%	7.12%	143.6%	24.32%	-15.51%	-	-
Enterprise Value (EV) ¹	19,807	15,973	17,146	37,918	45,326	38,717	36,609	34,108
Change	-	-19.36%	7.34%	121.15%	19.54%	-14.58%	-5.44%	-6.83%
P/E	17.9x	33.4x	44.8x	34.3x	29.1x	20.1x	16.7x	13.9x
PBR	2.32x	1.58x	1.67x	3.64x	4.18x	3.18x	2.78x	2.31x
PEG	-	-0.6x	-2.2x	0x	0.6x	0.9x	0.8x	0.7x
Capitalization / Revenue	3.28x	2.53x	2.85x	5.93x	5.86x	4.42x	3.99x	3.59x
EV / Revenue	3.43x	2.9x	3.26x	6.16x	5.86x	4.47x	3.81x	3.19x
EV / EBITDA	12.1x	12.7x	12.7x	25.7x	17.2x	12.7x	10.1x	8.04x
EV / EBIT	15x	23.7x	26.1x	45.4x	22.6x	15.7x	12.3x	9.4x
EV / FCF	15.6x	18.4x	38.5x	41.2x	24.6x	20.3x	14x	11.1x
FCF Yield	6.42%	5.43%	2.6%	2.43%	4.06%	4.93%	7.13%	9.03%
Dividend per Share ²	1.3	1.33	1.36	1.39	1.45	1.457	1.502	1.534
Rate of return	1.3%	1.81%	1.72%	0.72%	0.61%	0.72%	0.75%	0.76%
EPS ²	5.6	2.2	1.76	5.61	8.2	9.998	12.01	14.48
Distribution rate	23.2%	60.5%	77.3%	24.8%	17.7%	14.6%	12.5%	10.6%
Net sales ¹	5,777	5,517	5,252	6,152	7,741	8,659	9,607	10,682
EBITDA ¹	1,641	1,260	1,349	1,476	2,636	3,053	3,621	4,240
EBIT ¹	1,318	675	657	836	2,009	2,463	2,979	3,630
Net income ¹	1,058	418	343	1,065	1,558	1,928	2,297	2,758
Net Debt ¹	860	2,000	2,177	1,454	-7	412.7	-1,695	-4,196
Reference price ²	100.35	73.56	78.90	192.20	238.60	200.90	200.90	200.90
Nbr of stocks (in thousands)	188,812	189,959	189,721	189,720	189,996	190,663	-	-
Announcement Date	2/24/22	2/22/23	2/28/24	2/27/25	2/24/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.74x	2.09%	610B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	470B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	344B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	336B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	266B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	241B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	26.61x	6.52x	17.28x	2.29%	409.2B
Weighted average by Cap.	31.58x	7.62x	18.59x	1.96%